Efficacy and safety of aflibercept biosimilars compared to aflibercept in the treatment of neovascular age-related macular degeneration: a systematic review and meta-analysis. [PDF]
Zhou Y, Zhan Z, Wang Z, Liu C.
europepmc +1 more source
Predicting visual acuity using optical coherence tomography in patients with neovascular age-related macular degeneration. [PDF]
Moon S +5 more
europepmc +1 more source
Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): a network meta-analysis. [PDF]
Lucenteforte E +5 more
europepmc +1 more source
Biomarker-Specific Test-Retest Repeatabilities of Microperimetry in Neovascular Age-Related Macular Degeneration. [PDF]
Hinterhuber L +9 more
europepmc +1 more source
One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study. [PDF]
Mizuma R +6 more
europepmc +1 more source
CD8+ T cell aging is associated with macular neovascularization area change in neovascular age-related macular degeneration: a prospective cohort study. [PDF]
Thomsen AK +6 more
europepmc +1 more source
Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.
Korobelnik JF +8 more
europepmc +1 more source
Association of Air Pollution Exposure with Incident Cataract Surgery and Neovascular Age-Related Macular Degeneration in 2 French Nationwide Cohorts. [PDF]
Gayraud L +11 more
europepmc +1 more source
Correction to "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates". [PDF]
europepmc +1 more source
Flexible Loading Phase Treat-and-Extend Regimen with Faricimab for Neovascular Age-Related Macular Degeneration: A Real-World Study. [PDF]
Machida A +8 more
europepmc +1 more source

